Browsing by Author Mao, Qing

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 30 next >
Issue Date Title Author(s)
2019 Chinese guidelines on management of hepatic encephalopathy in cirrhosis Xu, Xiao-Yuan;Ding, Hui-Guo;Li, Wen-Gang;Jia, Ji-Dong;Wei, Lai;Duan, Zhong-Ping;Liu, Yu-Lan;Ling-Hu, En-Qiang;Zhuang, Hui;An, Ji-Hong;Cai, Da-Chuan;Chen, Guo-Feng;Chen, Hong-Song;Chen, Jing-Long;Chen, Yu;Cheng, Jun;Dou, Xiao-Guang;Feng, Zhi-Jie;Gao, Hui;Gao, Yan-Hang;Geng, Jia-Wei;Guo, Hui-Min;Guo, Wu-Hua;Han, Tao;Han, Ying;Huang, Yuan;Jiang, Jian-Ning;Jiang, Ying-An;Kong, Yuan-Yuan;Li, Cang-You;Li, Guang-Ming;Li, Jie;Li, Shu-Chen;Li, Tai-Sheng;Li, Yu-Fang;Liu, Jing-Feng;Liu, Xiao-Qing;Liu, Ying-Di;Lu, Lun-Gen;Luo, Xin-Hua;Ma, An-Lin;Ma, Xiong;Mao, Qing;Mao, Yi-Min;Nan, Yue-Min;Nie, Yu-Qiang;Ren, Hong;Ren, Wan-Hua;Shang, Jia;Wang, Lei;Wang, Yu-Ming;Wang, Xiao-Jun;Wu, Jing;Xie, Wei-Fen;Xie, Wen;Xin, Shao-Jie;Xing, Hui-Chun;Xu, Jian-Ming;Xu, Jie;Xu, Jing-Hang;Xu, You-Qing;Yan, Ming;Yang, Dong-Liang;Yang, Ji-Ming;Yang, Jin-Hui;Yang, Yong-Feng;Yang, Yong-Ping;You, Hong;Yu, Yan-Yan;Zhai, Suo-Di;Zhang, Chun-Qing;Zhang, Da-Zhi;Zhang, Ling-Yi;Zhang, Lun-Li;Zhang, Wen-Hong;Zhao, Jing-Min;Zhao, Ping;Zhao, Shou-Song;Zhu, Xuan;Zuo, Wei-Ze;Kang, Qian;Luo, Hao;Tan, Ning
2014 Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection Rao, Huiying;Wei, Lai;Carlos Lopez-Talavera, Juan;Shang, Jia;Chen, Hong;Li, Jun;Xie, Qing;Gao, Zhiliang;Wang, Lei;Wei, Jia;Jiang, Jianning;Sun, Yongtao;Yang, Ruifeng;Li, Hong;Zhang, Haiying;Gong, Zuojiong;Zhang, Lunli;Zhao, Longfeng;Dou, Xiaoguang;Niu, Junqi;You, Hong;Chen, Zhi;Ning, Qin;Gong, Guozhong;Wu, Shuhuan;Ji, Wei;Mao, Qing;Tang, Hong;Li, Shuchen;Wei, Shaofeng;Sun, Jian;Jiang, Jiaji;Lu, Lungen;Jia, Jidong;Zhuang, Hui
10-Feb-2021 Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial Shi, Lei;Huang, Hai;Lu, Xuechun;Yan, Xiaoyan;Jiang, Xiaojing;Xu, Ruonan;Wang, Siyu;Zhang, Chao;Yuan, Xin;Xu, Zhe;Huang, Lei;Fu, Jun-Liang;Li, Yuanyuan;Zhang, Yu;Yao, Wei-Qi;Liu, Tianyi;Song, Jinwen;Sun, Liangliang;Yang, Fan;Zhang, Xin;Zhang, Bo;Shi, Ming;Meng, Fanping;Song, Yanning;Yu, Yongpei;Wen, Jiqiu;Li, Qi;Mao, Qing;Maeurer, Markus;Zumla, Alimuddin;Yao, Chen;Xie, Wei-Fen;Wang, Fu-Sheng
2012 Effects of monomer structure on the morphology of polymer networks and the electro-optical properties of polymer-dispersed liquid crystal films Liu, Fang;Cao, Hui;Mao, Qing;Song, Ping;Yang, Huai
Jan-2022 Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial Wei, Lai;Zhao, Tingting;Zhang, Ji;Mao, Qing;Gong, Guozhong;Sun, Yongtao;Chen, Yongping;Wang, Maorong;Tan, Deming;Gong, Zuojiong;Li, Baosen;Niu, Junqi;Li, Shuchen;Gong, Huanyu;Zou, Liyun;Zhou, Wei;Jia, Zhengcai;Tang, Yan;Fei, Lei;Hu, Yang;Shang, Xiaoyun;Han, Junfeng;Zhang, Bei;Wu, Yuzhang
2012 Entecavir maleate versus Entecavir in Chinese patients with HBeAg-Positive Chronic Hepatitis B: Results at 48 and 96 weeks of a Randomized Double-blind Multicenter Clinical Trial Yu, Yanyan;Xu, Jinghang;Tang, Hong;Zhang, Dazhi;Mao, Qing;Li, Jun;Xu, Zhongnan;Zhang, Xiquan;Dai, Jun;Si, Chongwen
2014 High Response Rate and Good Tolerability of Genotype 6 Chronic Hepatitis C Patients to Pegylated Interferon alfa combining Ribavirin in China Wei, Lai;Gao, ZhiLiang;Mao, Qing;Zhang, Dazhi;Jiang, Jianning;Gong, Guozhong;Yin, Zhibiao;Xie, Qing;Sun, Jian;Rao, Huiying;Feng, Bo;Yang, Ruifeng;Zhang, Haiying
2019 Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results Liang, Xieer;Gao, Zhiliang;Xie, Qing;Zhang, Jiming;Sheng, Jifang;Cheng, Jun;Chen, Chengwei;Mao, Qing;Zhao, Wei;Ren, Hong;Tan, Deming;Niu, Junqi;Chen, Shijun;Pan, Chen;Tang, Hong;Wang, Hao;Mao, Yimin;Jia, Jidong;Ning, Qin;Xu, Min;Wu, Shanming;Li, Jun;Zhang, Xinxin;Zhang, Wenyan;Xiong, Cui;Hou, Jinlin
Nov-2020 LONG-TERM FOLLOW-UP OF PEGINTERFERON ALFA TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS IN PHASE III STUDY OF PEGINTERFERON ALFA-2b (40kD, Y SHAPE) (PEGBERON): A 4-YEAR FOLLOW-UP REPORT Wang, Guiqiang;Hou, Fengqin;Zhang, Min;Shang, Jia;Pan, Chen;Lv, Hui;Zhang, Mingxiang;Peng, Yanzhong;Xie, Qing;Wang, Maorong;Zhang, Dazhi;Chen, Yongping;Mao, Qianguo;Liu, Jiajun;Peng, Jie;Mao, Qing;Yang, Yongfeng;Yin, Chibiao;Han, Tao;Cheng, Na;Zhen, Zhen;Zhang, Jiming;Tan, Deming;Chen, Liang;Meng, Qinghua;Wang, Hao;Chen, Chengwei;Li, Baosen;Chen, Jun;Yin, Yalin;Sun, Li
2017 Long-term follow-up of peginterferon alpha treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Hou, Fengqin;Shang, Jia;Zhang, Mingxiang;Pan, Chen;Peng, Yan-zhong;Chen, Shijun;Zhang, Dazhi;Zhao, Wei;Mao, Qian-guo;Mao, Qing;Chen, Yongping;Wang, Maorong;Yin, Chibiao;Peng, Jie;Wang, Hao;Meng, Qinghua;Tan, Deming;Sun, Li;Wang, Guiqiang
2017 Long-term follow-up of peginterferon alpha treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Hou, Fengqin;Shang, Jia;Zhang, Mingxiang;Pan, Chen;Peng, Yan-zhong;Chen, Shijun;Zhang, Dazhi;Zhao, Wei;Mao, Qian-guo;Mao, Qing;Chen, Yongping;Wang, Maorong;Yin, Chibiao;Peng, Jie;Wang, Hao;Meng, Qinghua;Tan, Deming;Sun, Li;Wang, Guiqiang
2018 Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study Wang, Guiqiang;Hou, Fengqin;Zhang, Mingxiang;Zhang, Dazhi;Peng, Yanzhong;Shang, Jia;Chen, Shijun;Gong, Guozhong;Chen, Yongping;Wang, Maorong;Pan, Chen;Xie, Qing;Zhao, Wei;Liu, Jiajun;Peng, Jie;Mao, Qing;Yin, Chibiao;Zhang, Jiming;Zhen, Zhen;Chen, Liang;Tan, Deming;Wang, Hao;Mao, Qianguo;Meng, Qinghua;Chen, Chengwei;Sun, Li
2018 Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study Wang, Guiqiang;Hou, Fengqin;Zhang, Mingxiang;Zhang, Dazhi;Peng, Yanzhong;Shang, Jia;Chen, Shijun;Gong, Guozhong;Chen, Yongping;Wang, Maorong;Pan, Chen;Xie, Qing;Zhao, Wei;Liu, Jiajun;Peng, Jie;Mao, Qing;Yin, Chibiao;Zhang, Jiming;Zhen, Zhen;Chen, Liang;Tan, Deming;Wang, Hao;Mao, Qianguo;Meng, Qinghua;Chen, Chengwei;Sun, Li
2019 Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus Hou, Jinlin;Cui, Fuqiang;Ding, Yang;Dou, Xiaoguang;Duan, Zhongping;Han, Guorong;Jia, Jidong;Mao, Qing;Li, Jie;Li, Zengde;Liu, Zhihua;Wei, Lai;Xie, Qing;Yang, Xizhong;Zhang, Hua;Zhuang, Hui
Jun-2022 Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022) Liu, Zhihua;Chen, Zhongdan;Cui, Fuqiang;Ding, Yang;Gao, Yunfei;Han, Guorong;Jia, Jidong;Li, Jie;Li, Zengde;Liu, Yingxia;Mao, Qing;Wang, Ailing;Wang, Wei;Wei, Lai;Xia, Jianhong;Xie, Qing;Yang, Xizhong;Yin, Xueru;Zhang, Hua;Zhang, Liaoyun;Zhang, Wenhong;Zhuang, Hui;Dou, Xiaoguang;Hou, Jinlin
2018 On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy Wei, Lai;Shang, Jia;Xie, Qing;Jia, Zhansheng;Gao, Pujun;Shi, Junping;Chen, Xinyue;Wang, Jiefei;Xu, Min;Zhang, Liaoyun;Zhao, Yingren;Wang, Maorong;Mao, Qing;Zhao, Wei;Zhang, Zong;Jia, Jidong;Tang, Hong;Zhang, Jiming;Zheng, Xin;Xiong, Cui;Zhu, Mingfen
2018 On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy Wei, Lai;Shang, Jia;Xie, Qing;Jia, Zhansheng;Gao, Pujun;Shi, Junping;Chen, Xinyue;Wang, Jiefei;Xu, Min;Zhang, Liaoyun;Zhao, Yingren;Wang, Maorong;Mao, Qing;Zhao, Wei;Zhang, Zong;Jia, Jidong;Tang, Hong;Zhang, Jiming;Zheng, Xin;Xiong, Cui;Zhu, Mingfen
2017 Phase II b trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy Yang, Fu-Qiang;Rao, Gui-Rong;Wang, Gui-Qiang;Li, Yue-Qi;Xie, Yao;Zhang, Zhan-Qing;Deng, Cun-Liang;Mao, Qing;Li, Jun;Zhao, Wei;Wang, Mao-Rong;Han, Tao;Chen, Shi-Jun;Pan, Chen;Tan, De-Ming;Shang, Jia;Zhang, Ming-Xiang;Zhang, Yue-Xin;Yang, Ji-Ming;Chen, Guang-Ming
Sep-2021 Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial Gao, Yanhang;Kong, Fei;Song, Xinwen;Shang, Jia;Yao, Lvfeng;Xia, Jinyu;Peng, Yanzhong;Liu, Weidong;Gong, Huanyu;Mu, Mao;Cui, Hesong;Han, Tao;Chen, Wen;Wu, Xiaolu;Yang, Yongfeng;Yan, Xuebing;Jin, Zhenjing;Wang, Peng;Zhu, Qingjing;Chen, Liang;Zhao, Caiyan;Zhang, Dengke;Jin, Weili;Wang, Daidi;Wen, Xiuhong;Liu, Chunmei;Jia, Jidong;Mao, Qing;Ding, Yanhua;Jin, Xueyuan;Zhang, Zong;Mao, Qianguo;Li, Guangming;Niu, Junqi
2011 PREVALENCE OF HCV AND HOST IL28B GENOTYPES IN CHINA Wei, Lai;Lopez-Talavera, Juan Carlos;Rao, Huiying;Jia, Shang;Sun, Yongtao;You, Hong;Gong, ZuoJiong;Chen, Hong;Zhang, Lunli;Mao, Qing;Wang, Lei;Yang, RuiFeng;Li, Hong;Zhang, Haiying;Dou, Xiaoguang;Gao, Zhi-liang;Wei, Jia;Ning, Qin;Li, Jun;Xie, Qing;Chen, Zhi;Niu, Junqi;Gong, Guozhong;Ji, Wei;Jiang, Jia-ji;Li, Shuchen;Jiang, Jian-ning;Lu, Lungen;Sun, Jian;Tang, Hong;Wei, ShaoFeng;Wu, Shuhuan;Zhao, Longfeng
Showing results 1 to 20 of 30 next >